HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

amastatin

structure; inhibits aminopeptidase
Also Known As:
3-amino-2-hydroxy-5-methylhexanoyl-L-valyl-L-valyl-L-aspartic acid; 3-amino-2-hydroxy-5-methylhexanoyl-Val-Val-Asp; L-Aspartic acid, N-(N-(N-(3-amino-2-hydroxy-5-methyl-1-oxohexyl)-L-valyl)-L-valyl)-, (S-(R*,S*))-
Networked: 10 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Adam, Albert: 2 articles (04/2006 - 09/2005)
2. Fortin, Jean-Philippe: 2 articles (04/2006 - 09/2005)
3. Gera, Lajos: 2 articles (04/2006 - 09/2005)
4. Marceau, François: 2 articles (04/2006 - 09/2005)
5. Stewart, John M: 2 articles (04/2006 - 09/2005)
6. Guswanto, Azirwan: 1 article (05/2016)
7. Igarashi, Ikuo: 1 article (05/2016)
8. Ishizaki, Takahiro: 1 article (05/2016)
9. Munkhjargal, Tserendorj: 1 article (05/2016)
10. Takemae, Hitoshi: 1 article (05/2016)

Related Diseases

1. Tics (Tic)
2. Babesiosis (Piroplasmosis)
3. Seizures (Absence Seizure)
4. Neoplasms (Cancer)
5. Melanoma (Melanoma, Malignant)

Related Drugs and Biologics

1. ubenimex
2. CD13 Antigens (Alanine Aminopeptidase)
3. Bradykinin
4. lysyllysine (Lys-Lys)
5. Chromogenic Compounds
6. Arginine (L-Arginine)
7. B-9958
8. Protease Inhibitors (Protease Inhibitor)
9. Peptides (Polypeptides)
10. matrigel

Related Therapies and Procedures

1. Analgesia